{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:51:04Z","timestamp":1784325064739,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T00:00:00Z","timestamp":1668297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T00:00:00Z","timestamp":1668297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1245\/s10434-022-12790-9","type":"journal-article","created":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T00:02:49Z","timestamp":1668297769000},"page":"1574-1583","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of Pleural Thickness on Occurrence of Postoperative Complications in Patients with Malignant Pleural Mesothelioma"],"prefix":"10.1245","volume":"30","author":[{"given":"Toshinari","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Kadomatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harushi","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taketo","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Ozeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyofumi Fengshi","family":"Chen-Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,13]]},"reference":[{"key":"12790_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.11.005","author":"S Popat","year":"2021","unstructured":"Popat S, Baas P, Faivre-Finn C, et al. Malignant pleural mesothelioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021. https:\/\/doi.org\/10.1016\/j.annonc.2021.11.005.","journal-title":"Ann Oncol"},{"issue":"12","key":"12790_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145039","volume":"10","author":"E Taioli","year":"2015","unstructured":"Taioli E, Wolf AS, Camacho-Rivera M, et al. Determinants of survival in malignant pleural mesothelioma: a surveillance, epidemiology, and end results (SEER) study of 14,228 patients. PLoS One. 2015;10(12):e0145039. https:\/\/doi.org\/10.1371\/journal.pone.0145039.","journal-title":"PLoS One"},{"key":"12790_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2021.04.042","author":"M Hashimoto","year":"2021","unstructured":"Hashimoto M, Yamamoto H, Endo S, et al. Japanese current status of curative-intent surgery for malignant pleural mesothelioma. Ann Thorac Surg. 2021. https:\/\/doi.org\/10.1016\/j.athoracsur.2021.04.042.","journal-title":"Ann Thorac Surg"},{"issue":"Suppl 2","key":"12790_CR4","doi-asserted-by":"publisher","first-page":"s285","DOI":"10.21037\/jtd.2017.10.16","volume":"10","author":"S Ricciardi","year":"2018","unstructured":"Ricciardi S, Cardillo G, Zirafa CC, et al. Surgery for malignant pleural mesothelioma: an international guidelines review. J Thorac Dis. 2018;10(Suppl 2):s285\u201392. https:\/\/doi.org\/10.21037\/jtd.2017.10.16.","journal-title":"J Thorac Dis"},{"issue":"8","key":"12790_CR5","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1097\/JTO.0b013e3182208e3f","volume":"6","author":"D Rice","year":"2011","unstructured":"Rice D, Rusch V, Pass H, et al. Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group. J Thorac Oncol. 2011;6(8):1304\u201312. https:\/\/doi.org\/10.1097\/JTO.0b013e3182208e3f.","journal-title":"J Thorac Oncol"},{"issue":"18","key":"12790_CR6","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1200\/jco.2008.20.3943","volume":"27","author":"LM Krug","year":"2009","unstructured":"Krug LM, Pass HI, Rusch VW, et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol. 2009;27(18):3007\u201313. https:\/\/doi.org\/10.1200\/jco.2008.20.3943.","journal-title":"J Clin Oncol"},{"issue":"3","key":"12790_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10147-015-0925-1","volume":"21","author":"S Hasegawa","year":"2016","unstructured":"Hasegawa S, Okada M, Tanaka F, et al. Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial). Int J Clin Oncol. 2016;21(3):523\u201330. https:\/\/doi.org\/10.1007\/s10147-015-0925-1.","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"12790_CR8","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.ijrobp.2006.03.012","volume":"65","author":"AM Allen","year":"2006","unstructured":"Allen AM, Czerminska M, J\u00e4nne PA, et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys. 2006;65(3):640\u20135. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.03.012.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"12790_CR9","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ijrobp.2007.03.011","volume":"69","author":"DC Rice","year":"2007","unstructured":"Rice DC, Smythe WR, Liao Z, et al. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2007;69(2):350\u20137. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.03.011.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"12790_CR10","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/j.jtho.2016.08.147","volume":"11","author":"AK Nowak","year":"2016","unstructured":"Nowak AK, Chansky K, Rice DC, et al. The IASLC mesothelioma staging project: proposals for revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for pleural mesothelioma. J Thorac Oncol. 2016;11(12):2089\u201399. https:\/\/doi.org\/10.1016\/j.jtho.2016.08.147.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"12790_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jtcvs.2018.09.106","volume":"157","author":"M Hashimoto","year":"2019","unstructured":"Hashimoto M, Takeuchi J, Takuwa T, et al. Pleural thickness after neoadjuvant chemotherapy is a prognostic factor in malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2019;157(1):404\u201313. https:\/\/doi.org\/10.1016\/j.jtcvs.2018.09.106.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"12790_CR12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01428-2016","author":"M de Perrot","year":"2017","unstructured":"de Perrot M, Dong Z, Bradbury P, et al. Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma. Eur Respir J. 2017. https:\/\/doi.org\/10.1183\/13993003.01428-2016.","journal-title":"Eur Respir J"},{"key":"12790_CR13","volume-title":"TNM classification of malignant tumours","author":"JD Brierly","year":"2017","unstructured":"Brierly JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 8th edn. New York: Wiley-Blackwell; 2017.","edition":"8"},{"key":"12790_CR14","unstructured":"Travis WD, Brambilla E, Burke AP, et al. WHO classification of tumours of the lung, pleura, thymus and heart. Lyon: International Agency for Research on Cancer; 2015."},{"issue":"2","key":"12790_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187\u201396. https:\/\/doi.org\/10.1097\/SLA.0b013e3181b13ca2.","journal-title":"Ann Surg"},{"key":"12790_CR16","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. 2017. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm Accessed 29 May 2022."},{"key":"12790_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cells9041019","author":"Y Nishinaga","year":"2020","unstructured":"Nishinaga Y, Sato K, Yasui H, et al. Targeted phototherapy for malignant pleural mesothelioma: near-infrared photoimmunotherapy targeting podoplanin. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9041019.","journal-title":"Cells"},{"issue":"13","key":"12790_CR18","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1200\/jco.2017.76.6394","volume":"36","author":"HL Kindler","year":"2018","unstructured":"Kindler HL, Ismaila N, Armato SG 3rd, et al. Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2018;36(13):1343\u201373. https:\/\/doi.org\/10.1200\/jco.2017.76.6394.","journal-title":"J Clin Oncol"},{"issue":"11","key":"12790_CR19","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.jtho.2017.08.012","volume":"12","author":"V Verma","year":"2017","unstructured":"Verma V, Ahern CA, Berlind CG, et al. National Cancer Database Report on pneumonectomy versus lung-sparing surgery for malignant pleural mesothelioma. J Thorac Oncol. 2017;12(11):1704\u201314. https:\/\/doi.org\/10.1016\/j.jtho.2017.08.012.","journal-title":"J Thorac Oncol"},{"issue":"3","key":"12790_CR20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1183\/09031936.00063109","volume":"35","author":"A Scherpereel","year":"2010","unstructured":"Scherpereel A, Astoul P, Baas P, et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J. 2010;35(3):479\u201395. https:\/\/doi.org\/10.1183\/09031936.00063109.","journal-title":"Eur Respir J"},{"key":"12790_CR21","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00953-2019","author":"A Scherpereel","year":"2020","unstructured":"Scherpereel A, Opitz I, Berghmans T, et al. ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma. Eur Respir J. 2020. https:\/\/doi.org\/10.1183\/13993003.00953-2019.","journal-title":"Eur Respir J"},{"issue":"7","key":"12790_CR22","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/jso.25260","volume":"118","author":"M van Gerwen","year":"2018","unstructured":"van Gerwen M, Wolf A, Liu B, Flores R, Taioli E. Short-term outcomes of pleurectomy decortication and extrapleural pneumonectomy in mesothelioma. J Surg Oncol. 2018;118(7):1178\u201387. https:\/\/doi.org\/10.1002\/jso.25260.","journal-title":"J Surg Oncol"},{"issue":"2","key":"12790_CR23","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.athoracsur.2014.09.056","volume":"99","author":"E Taioli","year":"2015","unstructured":"Taioli E, Wolf AS, Flores RM. Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma. Ann Thorac Surg. 2015;99(2):472\u201380. https:\/\/doi.org\/10.1016\/j.athoracsur.2014.09.056.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"12790_CR24","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/jto.0000000000000064","volume":"9","author":"P Bovolato","year":"2014","unstructured":"Bovolato P, Casadio C, Bill\u00e8 A, et al. Does surgery improve survival of patients with malignant pleural mesothelioma? A multicenter retrospective analysis of 1365 consecutive patients. J Thorac Oncol. 2014;9(3):390\u20136. https:\/\/doi.org\/10.1097\/jto.0000000000000064.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"12790_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jtcvs.2014.03.01","volume":"148","author":"BM Burt","year":"2014","unstructured":"Burt BM, Cameron RB, Mollberg NM, et al. Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality. J Thorac Cardiovasc Surg. 2014;148(1):30\u20135. https:\/\/doi.org\/10.1016\/j.jtcvs.2014.03.01.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"12790_CR26","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1245\/s10434-020-09275-y","volume":"28","author":"A Nakamura","year":"2021","unstructured":"Nakamura A, Kondo N, Nakamichi T, et al. Complications and predictive factors for air leak\u2009>\u200910 days with neoadjuvant chemotherapy followed by pleurectomy\/decortication for malignant pleural mesothelioma. Ann Surg Oncol. 2021;28(6):3057\u201365. https:\/\/doi.org\/10.1245\/s10434-020-09275-y.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"12790_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ejcts.2004.12.028","volume":"27","author":"DJ Stewart","year":"2005","unstructured":"Stewart DJ, Martin-Ucar AE, Edwards JG, West K, Waller DA. Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations. Eur J Cardiothorac Surg. 2005;27(3):373\u20138. https:\/\/doi.org\/10.1016\/j.ejcts.2004.12.028.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"6","key":"12790_CR28","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/ejcts\/ezw215","volume":"50","author":"M Infante","year":"2016","unstructured":"Infante M, Morenghi E, Bottoni E, et al. Comorbidity, postoperative morbidity and survival in patients undergoing radical surgery for malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2016;50(6):1077\u201382. https:\/\/doi.org\/10.1093\/ejcts\/ezw215.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"12790_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/SLA.0b013e3182602af4","volume":"256","author":"B Ghanim","year":"2012","unstructured":"Ghanim B, Hoda MA, Winter MP, et al. Pretreatment serum C-reactive protein levels predict benefit from multimodality treatment including radical surgery in malignant pleural mesothelioma: a retrospective multicenter analysis. Ann Surg. 2012;256(2):357\u201362. https:\/\/doi.org\/10.1097\/SLA.0b013e3182602af4.","journal-title":"Ann Surg"},{"issue":"2","key":"12790_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/annonc\/mdh059","volume":"15","author":"MJ Byrne","year":"2004","unstructured":"Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol. 2004;15(2):257\u201360. https:\/\/doi.org\/10.1093\/annonc\/mdh059.","journal-title":"Ann Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12790-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12790-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12790-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T21:32:54Z","timestamp":1675891974000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12790-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,13]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["12790"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12790-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,13]]},"assertion":[{"value":"14 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have nothing to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}